<!DOCTYPE html>
<html>
<head>
    <meta charset="utf-8">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@picocss/pico@2/css/pico.classless.min.css">
    <title>Report 20-Sep-2025</title>
</head>
<body>
<main>
<a href="https://github.com/pathikrit/zeitgeist" target="_blank" rel="noopener" style="float: right;">
    <img src="https://github.githubassets.com/images/modules/logos_page/GitHub-Mark.png" alt="GitHub" width="30" height="30">
</a>
<h1>Daily Memo (20-Sep-2025)</h1>
<hr />
<h2>Key News Highlights</h2>
<ul>
<li><strong>Major Tariff &amp; Trade Policy Escalations:</strong>
<ul>
<li>Trump administration signals broad new tariffs, explicitly targeting pharma (66% likelihood), semiconductors (54% chance), and nearly all major U.S. trade partners: China, Canada, Mexico, South Korea, Japan, Taiwan, and the EU.</li>
<li>Microsoft raises Xbox prices in the U.S. due to tariff impact.</li>
</ul>
</li>
<li><strong>Labor Market &amp; Social Policy:</strong>
<ul>
<li>Unemployment risks rising above 7% by end of decade; labor market softening, but not crisis level.</li>
<li>Trump administration proposes $100,000 fee for H-1B visas, likely to choke tech labor supply.</li>
<li>Policymakers considering raising Social Security retirement age.</li>
</ul>
</li>
<li><strong>US Fiscal &amp; Debt Situation:</strong>
<ul>
<li>Federal debt is set to surpass $38T by year-end, almost certain.</li>
<li>Government spending increases (likely &gt;$500B), risk of government shutdown persists.</li>
</ul>
</li>
<li><strong>Inflation, Rates &amp; Fed Policy:</strong>
<ul>
<li>Inflation above 3% is very likely for 2025, with core and headline both expected to remain well above the Fed’s old targets.</li>
<li>Multiple Fed rate cuts by year-end seem probable, but the bar for additional hikes or emergency moves remains high.</li>
<li>US recession risk in 2025 remains relatively low.</li>
</ul>
</li>
<li><strong>Industrial &amp; Climate Policy:</strong>
<ul>
<li>Solar installations likely to reach at least ~30-40 GW (not an acceleration), and large offshore wind project permits being revoked.</li>
</ul>
</li>
<li><strong>Tech &amp; Crypto:</strong>
<ul>
<li>Nvidia expected to surpass all peers as world’s largest market cap company by year-end.</li>
<li>Bitcoin is on track for $130,000+ (60%+ odds to hit or exceed).</li>
<li>Large Monad airdrop is expected before year-end.</li>
</ul>
</li>
<li><strong>Healthcare:</strong>
<ul>
<li>Pharma tariffs loom, with broad industry impact expected.</li>
<li>Multiple infectious disease headlines: polio, Chagas, and flesh-eating bacteria are being tracked (moderate but growing risks).</li>
</ul>
</li>
<li><strong>Geopolitical &amp; Security:</strong>
<ul>
<li>US airstrikes continuing; Middle East/Gaza tensions escalating, with refugee and force-displacement risk.</li>
<li>UN Security Council moving to snapback sanctions on Iran.</li>
<li>Russian fighter jets violate Estonian airspace, reinforcing global defense risk premium.</li>
</ul>
</li>
<li><strong>Other Notables:</strong>
<ul>
<li>SpaceX’s launch rate remains extreme (well over 140 launches expected this year).</li>
<li>Walmart embroiled in safety and fraud probe for online marketplace.</li>
<li>AI regulation: high likelihood of new US safety legislation.</li>
</ul>
</li>
</ul>
<hr />
<h2>1. Macroeconomic Environment</h2>
<h3>US Growth, Inflation &amp; Fed Policy</h3>
<ul>
<li><strong>Growth:</strong> US GDP growth for 2025 will likely be moderate (1.5-2.5%). Recession risk is viewed as low. Odds for a &quot;Trump boom&quot; (5%+ GDP) are limited.</li>
<li><strong>Inflation:</strong> Both headline and core inflation are firmly expected above 3% for 2025. Any rapid drop below 2.5% is highly unlikely.</li>
<li><strong>Labor Market:</strong> Unemployment is expected to climb throughout the decade—7%+ is the base case, raising risk for sectors reliant on flexible/cheap labor or consumer confidence.</li>
<li><strong>Rates:</strong> The current trajectory points to multiple (up to 3) Fed rate cuts over the next 12-18 months, with rates settling in the 3.5%-3.75% range. No material risk of hikes or emergency rate policy changes.</li>
</ul>
<p><strong>Implications:</strong></p>
<ul>
<li>Short and intermediate-duration US bonds regain relative appeal as inflation remains stickier than target but rate cycle softens.</li>
<li>Persistent inflation could keep real yields suppressed and support for hard assets (commodities, gold, real estate).</li>
</ul>
<h3>Fiscal Outlook &amp; Debt</h3>
<ul>
<li><strong>Federal Debt:</strong> Strong consensus that debt will cross $38T by year-end, trending toward $40T+ under the Trump administration.</li>
<li><strong>Spending:</strong> Increased spending (&gt;$500B) is highly likely, with potential for “fiscal cliffs” around shutdowns or entitlement reform.</li>
</ul>
<p><strong>Implications:</strong></p>
<ul>
<li>Long-term US sovereign risk rises modestly. Slight elevation in credit risk, but no imminent crisis.</li>
<li>Watch for potential downside in US Treasuries if debt trajectory triggers new credit downgrades or sparks bond market dislocation.</li>
</ul>
<hr />
<h2>2. Policy, Trade, and Regulation</h2>
<h3>Trade &amp; Tariffs</h3>
<ul>
<li>Broad and sweeping US tariff increases are extremely likely across all major trading partners (China, Canada, Mexico, Taiwan, Japan, South Korea, plus parts of the EU).</li>
<li>Pharma and semiconductor sectors are specifically highlighted for near-term new tariffs.</li>
<li>Large increases in US tariff revenue are likely.</li>
<li>H-1B visa fee shock and broader anti-immigration stance will stress US tech labor supply and cost structures.</li>
</ul>
<p><strong>Implications:</strong></p>
<ul>
<li>Near-term negative for US importers (retail, consumer hardware, auto), as input costs rise.</li>
<li>US tech companies exposed to supply chains in China/India especially vulnerable, with labor access further constrained.</li>
<li>Pharma faces direct cost and supply chain shocks.</li>
<li>Potential for retaliatory tariffs, pressuring ag, autos, and heavy US exporters.</li>
<li>Ensuing sectors to benefit: domestic manufacturing, supply chain “localization” enablers, select automation, and robotics.</li>
</ul>
<h3>Social Policy &amp; Benefits</h3>
<ul>
<li>Social Security reform, especially raising retirement age, now under active consideration; a policy inflection could dampen consumer confidence among 50+ age group longer term.</li>
</ul>
<hr />
<h2>3. Sector &amp; Thematic Focus</h2>
<h3>Technology, Semiconductors &amp; AI</h3>
<ul>
<li><strong>Nvidia</strong> is strongly favored to become the world’s largest public company, underpinned by US semiconductor output growth (&gt;7%).</li>
<li><strong>Microsoft, Apple, Alphabet, Tesla</strong>: None are likely to overtake Nvidia in valuation in near-term.</li>
<li><strong>AI regulation</strong>: US legislative action on AI safety is considered probable this year.</li>
<li><strong>Labor supply shocks</strong>: H-1B cracks and tariff cost-push will compound wage and margin pressures, particularly for large tech.</li>
<li><strong>Crypto &amp; Blockchain</strong>: Strong outlook for Bitcoin (very likely to cross $130K) and Ripple. Ethereum downside is limited (sub-$1,000 risk is minimal).</li>
</ul>
<p><strong>Implications:</strong></p>
<ul>
<li>Remain overweight US semiconductor capital equipment, design, and enabling AI infrastructure.</li>
<li>US mega-cap tech faces risk/volatility around labor and trade (especially those with India/China exposure).</li>
<li>Tariff inflation on consumer gadgets (see Xbox price hikes) hints at potential cost pass-through across hardware names.</li>
</ul>
<h3>Healthcare &amp; Pharma</h3>
<ul>
<li>High likelihood of direct US pharma sector tariffs.
<ul>
<li><strong>US pharma MNCs</strong>: Margin pressure, supply chain noise; benefit to domestic generics and US API manufacturers.</li>
<li>Healthcare providers: Some input cost pressure, but mostly a manufacturer/importer issue.</li>
</ul>
</li>
<li>Disease flags: polio, “kissing bug,” flesh-eating bacteria—no systemic threat yet, but risk monitoring is warranted for biotech and medtech diagnostics.</li>
</ul>
<h3>Energy &amp; Climate</h3>
<ul>
<li><strong>Solar:</strong> 2025’s US installation rate will be strong (30-40 GW), but not at the upper end of expectations; no new upside momentum indicated.</li>
<li><strong>Wind:</strong> Offshore wind development faces new regulatory and permitting headwinds (revoked permits).</li>
<li><strong>Fossil/Utilities:</strong> No sector-specific news, but continued renewables policy uncertainty favors balance in energy holdings.</li>
</ul>
<p><strong>Implications:</strong></p>
<ul>
<li>Maintain a measured approach to renewables and energy transition equities; overweight US traditional utilities and infrastructure during policy flux.</li>
</ul>
<h3>Retail, Real Estate, Consumer:</h3>
<ul>
<li>Walmart faces probes on third-party sales quality—potential for short- and medium-term operational or regulatory drag.</li>
<li>Persistent consumer inflation pressure, and possible entitlements/benefits tightening, will weigh on broadline retail and discretionary, though employment remains stable enough to avoid severe downside.</li>
<li>Government shutdown risk may affect sector sentiment.</li>
</ul>
<h3>Aerospace &amp; Defense:</h3>
<ul>
<li><strong>SpaceX</strong>: Robust launch schedule continues, signaling strong underlying demand for US launch vehicles.</li>
</ul>
<hr />
<h2>4. Key Individual Equities &amp; Assets</h2>
<ul>
<li><strong>Nvidia</strong>: Top global market cap leader trajectory.</li>
<li><strong>Microsoft</strong>, <strong>Apple</strong>, <strong>Alphabet</strong>, <strong>Tesla</strong>: Not expected to retake leadership soon; face cost, labor, regulatory threats over next six months.</li>
<li><strong>Bitcoin</strong>: Momentum sustained to $130K+, with modest but meaningful sovereign bid risk.</li>
<li><strong>Ripple</strong>: Favored for crypto outperformance in 2025.</li>
<li><strong>Walmart</strong>: Potential for headline risk-driven weakness due to marketplace probe.</li>
<li><strong>Microsoft</strong>: Tariff exposure showing in consumer segment price hikes.</li>
<li><strong>SpaceX/Space sector</strong>: Continue to benefit from government and private launch demand.</li>
</ul>
<hr />
<h2>Actionable Watchlist</h2>
<ul>
<li>Monitor tariff announcements and retaliatory risks closely; overweight domestic supply chain enablers.</li>
<li>Look for further details/fallout from H-1B policy and offshore wind permit revocations.</li>
<li>Stay alert to signals for escalating infectious disease risk and new regulatory actions (AI, safety, pharma).</li>
</ul>
<hr />
<p><strong>End of memo.</strong></p>

</main>
</body>
</html>
